Current treatment in Parkinson's disease
Stefanache, F.; Pendefunda, G.H.
Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 94(2): 411-416
1990
ISSN/ISBN: 0048-7848 PMID: 2100863 Document Number: 350845
Document emailed within 1 workday
Related Documents
Kuno, S. 1999: Current diagnosis and treatment of Parkinson's disease Rinsho Shinkeigaku 39(1): 104-106Hingtgen, C.M.; Siemers, E. 1998: The treatment of Parkinson's disease: current concepts and rationale Comprehensive Therapy 24(11-12): 560-566
Aminoff, M.J. 1987: Parkinson's disease in the elderly: current management strategies Geriatrics 42(7): 31-37
Forjaz, M.J.; Frades-Payo, B.; Martínez-Martín, P. 2009: The current state of the art concerning quality of life in Parkinson's disease: II. Determining and associated factors Revista de Neurologia 49(12): 655-660
Jagadeesan, A.J.; Murugesan, R.; Vimala Devi, S.; Meera, M.; Madhumala, G.; Vishwanathan Padmaja, M.; Ramesh, A.; Banerjee, A.; Sushmitha, S.; Khokhlov, A.N.; Marotta, F.; Pathak, S. 2017: Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review Acta Bio-Medica: Atenei Parmensis 88(3): 249-262
Obeso, J.A.; Rodriguez-Oroz, M.C.; Rodriguez, M.; DeLong, M.R.; Olanow, C.W. 2000: Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model Annals of Neurology 47(4 Suppl 1): S22
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Bertrand, E.; Lechowicz, W.; Szpak, G.M.; Dymecki, J. 1997: Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease Neurologia i Neurochirurgia Polska 31(2): 295-302
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Friedman, A.; Galazka-Friedman, J. 2001: The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress Advances in Neurology 86: 137-142
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Nikitin, I.P.; Leopa, N.A. 1979: Wolff-Parkinson-White syndrome (WPW) and current approaches to diagnosis and treatment Kardiologiia 19(7): 110-115
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Rabasseda, X. 1999: Perspectives in the treatment of Parkinson's disease: COMT inhibitors open up new treatment strategies Drugs of Today 35(9): 701-717
Bergus, G. 1996: Treatment of Parkinson's disease Journal of Family Practice 42(5): 457-458
Vijayaraghavan, A.; Radhakrishnan, K. 1996: Treatment of Parkinson's disease Neurology India 44(4): 177-182
Jameson, H.D. 1972: Treatment of Parkinson's disease Journal of the Kentucky Medical Association 70(4): 304-307
Jiménez-Jiménez, F.J. 1999: The treatment of Parkinson disease Medicina Clinica 112(7): 257-258